Clinico-prognostic relevance of quantitative immunophenotyping in B- cell chronic lymphocytic leukemia with emphasis on the expression of CD20 antigen and surface immunoglobulins

European Journal of Haematology

Volumn 60, Issue 1, 1998, Pages 47-52

  Molica, S ^a,b   Levato, D ^a   Dattilo, A ^a   Mannella, A ^a  

^a PUGLIESE CIACCIO HOSPITAL   (Italy)

^b NONE   (Italy)

Author keywords

CD20 antigen density; Immunological score; Prognosis; Sm Ig expression

Indexed keywords

CD20 ANTIGEN; LYMPHOCYTE MEMBRANE IMMUNOGLOBULIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LEUKEMIA; CANCER MORTALITY; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL EXAMINATION; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOPHENOTYPING; LIFE EXPECTANCY; LYMPHOCYTOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031974145     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1998.tb00995.x     Document Type: Article

References (30)

1. FREEDMAN AS, BOYD AW, RIEBER FR, et al. Normal cellular counterparts of B cell chronic lymphocytic leukemia. Blood 1987; 70: 418-427.
2. BENNETT JM, CATOVSKY D, DANIEL MT, et al. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. J Clin Path 1989; 42: 567-584.
3. LEGAC E, CHASTANG C, BINET JL, MICHEL A, DEBRE P, MERLE-BERAL H. Proposal for a phenotypic classification of B-chronic lymphocytic leukemia: relationship with prognostic factors. Leuk Lymph 1991; 5 (suppl 1): 53-58.
4. KUREC AS, THREATTE GA, GOTTLIEB AJ, SMITH JR, ANDERSON J, DAVEY FR. Immunophenotypic subclassification of chronic lymphocytic leukaemia (CLL). Br J Haematol 1992; 81: 45-51.
5. GEISLER CH, LARSEN JK, HANSEN NE, et al. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood 1991; 78: 1795-1802.
6. NEWMAN RA, PETERSON B, DAVEY FR, et al. Phenotypic markers and BCL-1 gene rearrangement in B-cell chronic lymphocytic leukemia: a Cancer and Leukemia Group B Study. Blood 1993; 82: 1239-1246.
7. MATUTES E, OWUSU-ANKOMAH K, MORILLA R, et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994; 8: 1640-1645.
8. ORFAO A, GONZALES M, SAN MIGUEL JF, et al. B-cell chronic lymphocytic leukaemia: prognostic value of the immunophenotype and the clinico-haematological features. Am J Hematol 1989; 31: 26-31.
9. LAVABRE-BERTRAND T, DUPERRAY C, BRUNET C, et al. Quantification of CD24 and CD45 antigens in parallel allows a precise determination of B-cell maturation stage: relevance for the study of B-cell neoplasias. Leukemia 1994; 8: 402-408.
10. LAVABRE-BERTRAND T, JANOSSY G, EXBRAYAT C, BOURQUARD P, DUPERRRAY C, NAVARRO M. Leukemia associated changes identified by quantitative flow cytometry: II. CD5 over-expression and monitoring in B-CLL. Leukemia 1994; 8: 1557-1563.
11. MOLICA S, MANNELLA A, DATTILO A, et al. Differential expression of bcl-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis. Haematologica 1996; 81: 302-309.
12. INTERNATIONAL WORKSHOP ON CHRONIC LYMPHOCYTIC LEUKEMIA. Chronic lymphocytic leukemia: recommendations for diagnosis, staging, and response criteria. Ann Intern Med 1989; 110: 236-238.
13. BINET JL, AUQUIER A, DIGHIERO G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981; 48: 198-206.
14. ROZMAN C, MONTSERRAT E, RODRIGUEZ-FERNANDEZ JM, et al. Bone marrow histological pattern. The best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases. Blood 1984; 64: 642-649.
15. MONTSERRAT E, SANCHEZ-BISONO J, VINOLAS N, ROZMAN C. Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significance. Br J Haematol 1986; 62: 567-576.
16. MOLICA S. Progression and survival studies in early chronic lymphocytic leukemia. Blood 1991; 78: 895-899.
17. KNAPP W, DORKEN B, GILKS WR, et al. Leukocyte Typing IV. White cell differentiation antigens. Oxford: Oxford University Press, 1989.
18. KAPLAN EL, MEIER P. Non-parametric estimation of incomplete observations. Am J Stat Assoc 1958; 53: 457-467.
19. PETO R, PIKE MC, ARMITAGE P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analyses and examples. Br J Cancer 1977; 35: 1-39.
20. COX DR. Regression models and life tables. J R Stat Assoc 1972; 34: 187-220.
21. ALMASRI NM, DUQUE RE, ITURRASPE J, EVERETT E, BRAYLAN RC. Reduced expression of CD20 antigen as characteristic marker for chronic lymphocytic leukemia. Am J Hematol 1992; 40: 259-263.
22. MADDY AH, SANDERSON A, MACKIE MJ, SMITH SK. The role of cell maturation in the generation of phenotypic heterogeneity in B-cell chronic lymphocytic leukaemia. Immunology 1989; 68: 346-352.
23. DAWSON CD, SCHEPPLER JA, NICHOLSON JK, HOLMAN RC. Enumeration of antigen sites on cells by flow cytometry. Pathobiology 1991; 59: 57-64.
24. PONCELET P, CARAYON P. Cytofluorimetric quantification of cell surface antigen by indirect immunofluorescence using monoclonal antibodies. J Immunol Meth 1985; 85: 65-74.
25. BARTHOLMAI B, TEFFERI A, WITZIG TE, LI CY, HANSON CA, PHYLIKY RL. Heterogeneity and clinical relevance of the intensity of CD20 and immunoglobulin light chain expression in B-cell chronic lymphocytic leukemia. Blood 1995; 86 (suppl 1): 828a.
26. ZOMAS AP, MATUTES E, MORILLA R, OWUSU-ANKOMAH K, SEON BK, CATOVSKY D. Expresssion of the immunoglobulin-associated protein B29 in B cell disorders with monoclonal antibody SN8 (CD79b). Leukemia 1996; 10: 1966-1970.
27. MATUTES E, MOREAU E, ZOMAS AR et al. Revised CLL scoring system including the monoclonal antibody SN8 (CD79b). VII International Workshop on CLL, Crete (GR), 2-4 May, 1997: abstr, 20a.
28. MONTSERRAT E. Chronic lymphoproliferative disorders. Curr Opin Oncol 1997; 9: 34-41.
29. TEFFERI A, CHIN-YANG LI, PHYLIKY L. Correlation of clinical outcome with the degree of surface immunoglobulin (sIg) expression in B-cell chronic lymphocytic leukemia. Am J Clin Pathol 1989; 92: 82-85.
30. RUBIEN JK, DARWIN BELL P, FRIZZELL RA, TEDDER TF. CD20 directly regulates transmembrane ion flux in B-lymphocytes. In: Leukocyte typing IV. White cell differentiation antigens. KNAPP W, DORKEN B, GILKS WR, et al. (eds) Oxford: Oxford University Press, 1989: 51-54.